As the iconic synth-maker enters a new era under inMusic, we speak to several key figures at the company to ask if it can ...
Understanding who will end up paying for the higher costs means understanding how manufacturing, trade and supply chains function — and how costs build along each step of the complex process. Take ...
Quality, affordable health care is crucial to aging well, and Medicare makes it possible for millions of older adults in the ...
West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2023, West had total debt outstanding of $206 million. West has ...
Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 billion of non-cash charges related to manufacturing resizing ...
It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the ...
Shareholder distributions are appropriate. Capital intensity of the industry remains low and gross margins high. In addition, Cochlear enjoys high cash conversion, enabling it to typically pay out 70% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results